Kane Biotech Financials
| KNBIF Stock | USD 0.08 0 3.13% |
With this module, you can analyze Kane financials for your investing period. You should be able to track the changes in Kane Biotech individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Kane |
The data published in Kane Biotech's official financial statements typically reflect Kane Biotech's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Kane Biotech's quantitative information. For example, before you start analyzing numbers published by Kane accountants, it's essential to understand Kane Biotech's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Kane Biotech Stock Summary
Kane Biotech competes with Sino Biopharmaceutica, Defence Therapeutics, Aileron Therapeutics, and Enlivex Therapeutics. Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada. Kane Biotech is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| Business Address | 290-100 Innovation Drive, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | kanebiotech.com |
| Phone | 204 453 1301 |
| Currency | USD - US Dollar |
Kane Biotech Key Financial Ratios
There are many critical financial ratios that Kane Biotech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Kane Biotech reports annually and quarterly.Kane Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kane Biotech's current stock value. Our valuation model uses many indicators to compare Kane Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kane Biotech competition to find correlations between indicators driving Kane Biotech's intrinsic value. More Info.Kane Biotech is rated below average in return on equity category among its peers. It is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kane Biotech's earnings, one of the primary drivers of an investment's value.Kane Biotech Systematic Risk
Kane Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Kane Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-two with a total number of output elements of nineteen. The Beta measures systematic risk based on how returns on Kane Biotech correlated with the market. If Beta is less than 0 Kane Biotech generally moves in the opposite direction as compared to the market. If Kane Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Kane Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Kane Biotech is generally in the same direction as the market. If Beta > 1 Kane Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Kane Biotech December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Kane Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kane Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kane Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Kane OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kane Biotech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 29.8 | |||
| Value At Risk | (2.81) | |||
| Potential Upside | 0.6536 |
Complementary Tools for Kane OTC Stock analysis
When running Kane Biotech's price analysis, check to measure Kane Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kane Biotech is operating at the current time. Most of Kane Biotech's value examination focuses on studying past and present price action to predict the probability of Kane Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kane Biotech's price. Additionally, you may evaluate how the addition of Kane Biotech to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Transaction History View history of all your transactions and understand their impact on performance |